Featured Article
Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before interest and taxes rose 22 % to $674 million over the same period last year. A review of Boston Scientific’s 24 April earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Pricing was not mentioned in their earnings call. Margins were briefly mentioned by…
Read MoreIn This Issue
When measuring market volume, markets are usually measured by unit rather than transactions. While this historic basis for measuring markets has proven…
Read More Nanotechnology has buzz in today’s business community, but will it be the next big thing? From science fiction and popular science periodicals,…
Read More IAR Systems, a Swedish company with operations in the US and around the globe, is providing products and services to make developing…
Read More Getting a handle on the customer moves to a new corporate hierarchy: The Chief Customer Officer, the outgrowth of “customer centric” initiatives.…
Read More